Financial
Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.
Figures cover the whole listed group, not this business alone.
Leica Biosystems
HQ Germany · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Strong
Customer rating
No reviews yet
Financial health
Band: StrongOwned by Danaher (DHR)
Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.
Figures cover the whole listed group, not this business alone.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | US$24.6bn | +3.0% | US$4.7bn | US$3.6bn | Danaher group |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media involving Leica Biosystems found in HSH's search of the last 24 months.
Cyber & information governance
No data breaches or cyber incidents involving Leica Biosystems found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Apr 2025: Leica Biosystems began a US FDA Class 2 recall of 77 HistoCore PELORIS 3 tissue processors over a leak in manifold tubing; more serial numbers were added in Aug 2025 and the recall is listed as open.
Contract performance
Sep 2025: trusts in the South West London Pathology network selected Leica Biosystems' Aperio GT 450 DX scanners with Indica Labs' HALO AP for digital pathology, funded through NHS England's diagnostics digital capability programme.
Competitors
No competitors linked yet.